LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cancer, breast, article, google, scholar, pubmed, cas, chemotherapy, response, foxp, patients, neoadjuvant, prognostic, clin, res, regulatory, oncol, tregs, research, intratumoral, lymphocytes, complete, cells, tumor, izmir, clinical, pathologic, survival, predictive, pcr, rates, outcome, oncology, privacy, cookies, content, factors, locally, advanced, study, treg, pathological, infiltration, access, expression, kim, immune, turkey, department, publish,

Topics {✒️}

granulocyte/macrophage-colony stimulating factor-secreting month download article/chapter neoadjuvant anthracycline/taxane-based chemotherapy tumour-infiltrating foxp3+ lymphocytes de la torre-cabrera tumor-infiltrating lymphocytes isolated triple-negative breast cancer balancing immune response-crosstalk higher pre-chemotherapy tregs tumor t-lymphocyte infiltration predict clinical outcome tumour-infiltrating lymphocytes potential therapeutic target full article pdf doxorubicin-based neoadjuvant chemotherapy privacy choices/manage cookies immunosuppressive regulatory tcells regulatory tcell infiltration van de rjin tumor infiltrating lymphocytes good clinical outcome intratumoral foxp3+ regulatory pathologic complete response foxp3+ tumor-infiltrating meta-analysis related subjects cd8+ lymphocyte infiltration transcription factor foxp3 intratumoral foxp3+ lymphocytes pathological complete response high-risk patients independent predictive factor human malignancies based locallyadvanced breast cancer breast cancer progression inflammatory breast cancer breast cancer subtype operable breast cancer choose adjuvant therapies dokuz eylul university intratumoral foxp3+ tregs van nes jg breast cancer subtypes lower intratumoral infiltration situ immune response antitumor immune response anti-tumor effects early breast cancer european economic area mihm mc jr

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs
         description:This study aimed to investigate the prognostic and predictive effect of FOXP3+ Tregs together with clinicopathologic factors in locally advanced breast cancer (LABC) patients. The medical records of 101 LABC patients who received neoadjuvant chemotherapy (NAC) between 2005 and 2012 were evaluated retrospectively. The density of intratumoral FOXP3+ lymphocytes in paraffin-embedded tissues was assessed by immunohistochemical analyses in appropriate cases. The relationship with clinicopathologic features, prognosis and chemotherapy response was investigated. HR(–) and HER2(+) tumors tended to have higher pre-chemotherapy Tregs than HR(+) tumors, and significantly higher pathologic complete response (PCR) rates were observed in these patients. Treg decline after NAC was associated with better pathological response rates. Lower intratumoral infiltration of FOXP3+ Tregs after NAC (<3.4/HPF) was significantly associated with higher PCR rates for breast, and close to the significance limit for total (or both for breast and axillary) PCR rates (PCR for breast: 25 vs. 2.9 % for low vs. high Treg, p = 0.001; PCR for breast + axillary tissue: 13.9 vs. 0 %, p = 0.05). Despite better PCR rates, patients with high intratumoral Treg infiltrates (≥11.5/HPF) before chemotherapy had significantly shorter overall survival than patients with low Treg infiltrates (<11.5/HPF). Cox multivariate regression analyses demonstrated that the density of Treg infiltration before chemotherapy was the strongest predictor for survival. This study established the predictive and prognostic effect of intratumoral FOXP3+ Tregs in LABC patients. To predict clinical outcome, evaluation of FOXP3+ Tregs in tumoral tissues before and after NAC should be considered for these high-risk patients.
         datePublished:2013-07-09T00:00:00Z
         dateModified:2013-07-09T00:00:00Z
         pageStart:1047
         pageEnd:1062
         sameAs:https://doi.org/10.1007/s10585-013-9602-9
         keywords:
            Breast cancer
            FOXP3+ T lymphocytes
            Neoadjuvant chemotherapy
            Pathologic complete response
            Cancer Research
            Biomedicine
            general
            Oncology
            Hematology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig4_HTML.gif
         isPartOf:
            name:Clinical & Experimental Metastasis
            issn:
               1573-7276
               0262-0898
            volumeNumber:30
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lutfiye Demir
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Seyran Yigit
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hulya Ellidokuz
               affiliation:
                     name:Dokuz Eylul University
                     address:
                        name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cigdem Erten
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Isil Somali
               affiliation:
                     name:Dokuz Eylul University
                     address:
                        name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuksel Kucukzeybek
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ahmet Alacacioglu
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Suna Cokmert
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alper Can
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Murat Akyol
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ahmet Dirican
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vedat Bayoglu
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aysegul Akder Sari
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mustafa Oktay Tarhan
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs
      description:This study aimed to investigate the prognostic and predictive effect of FOXP3+ Tregs together with clinicopathologic factors in locally advanced breast cancer (LABC) patients. The medical records of 101 LABC patients who received neoadjuvant chemotherapy (NAC) between 2005 and 2012 were evaluated retrospectively. The density of intratumoral FOXP3+ lymphocytes in paraffin-embedded tissues was assessed by immunohistochemical analyses in appropriate cases. The relationship with clinicopathologic features, prognosis and chemotherapy response was investigated. HR(–) and HER2(+) tumors tended to have higher pre-chemotherapy Tregs than HR(+) tumors, and significantly higher pathologic complete response (PCR) rates were observed in these patients. Treg decline after NAC was associated with better pathological response rates. Lower intratumoral infiltration of FOXP3+ Tregs after NAC (<3.4/HPF) was significantly associated with higher PCR rates for breast, and close to the significance limit for total (or both for breast and axillary) PCR rates (PCR for breast: 25 vs. 2.9 % for low vs. high Treg, p = 0.001; PCR for breast + axillary tissue: 13.9 vs. 0 %, p = 0.05). Despite better PCR rates, patients with high intratumoral Treg infiltrates (≥11.5/HPF) before chemotherapy had significantly shorter overall survival than patients with low Treg infiltrates (<11.5/HPF). Cox multivariate regression analyses demonstrated that the density of Treg infiltration before chemotherapy was the strongest predictor for survival. This study established the predictive and prognostic effect of intratumoral FOXP3+ Tregs in LABC patients. To predict clinical outcome, evaluation of FOXP3+ Tregs in tumoral tissues before and after NAC should be considered for these high-risk patients.
      datePublished:2013-07-09T00:00:00Z
      dateModified:2013-07-09T00:00:00Z
      pageStart:1047
      pageEnd:1062
      sameAs:https://doi.org/10.1007/s10585-013-9602-9
      keywords:
         Breast cancer
         FOXP3+ T lymphocytes
         Neoadjuvant chemotherapy
         Pathologic complete response
         Cancer Research
         Biomedicine
         general
         Oncology
         Hematology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig4_HTML.gif
      isPartOf:
         name:Clinical & Experimental Metastasis
         issn:
            1573-7276
            0262-0898
         volumeNumber:30
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lutfiye Demir
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Seyran Yigit
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hulya Ellidokuz
            affiliation:
                  name:Dokuz Eylul University
                  address:
                     name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cigdem Erten
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Isil Somali
            affiliation:
                  name:Dokuz Eylul University
                  address:
                     name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuksel Kucukzeybek
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ahmet Alacacioglu
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Suna Cokmert
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alper Can
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Murat Akyol
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ahmet Dirican
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vedat Bayoglu
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aysegul Akder Sari
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mustafa Oktay Tarhan
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical & Experimental Metastasis
      issn:
         1573-7276
         0262-0898
      volumeNumber:30
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Dokuz Eylul University
      address:
         name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Dokuz Eylul University
      address:
         name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lutfiye Demir
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Seyran Yigit
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Hulya Ellidokuz
      affiliation:
            name:Dokuz Eylul University
            address:
               name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Cigdem Erten
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Isil Somali
      affiliation:
            name:Dokuz Eylul University
            address:
               name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Yuksel Kucukzeybek
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Ahmet Alacacioglu
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Suna Cokmert
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Alper Can
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Murat Akyol
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Ahmet Dirican
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Vedat Bayoglu
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Aysegul Akder Sari
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Mustafa Oktay Tarhan
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(169)

• How much money does https://www.springernature.com/gp/authors generate?
• What's the income generated by https://link.springernature.com/home/ each month?
• Income figures for https://order.springer.com/public/cart
• Learn about the earnings of https://submission.nature.com/new-submission/10585/3
• How profitable is https://www.springernature.com/gp/librarians/licensing/agc/journals?
• How much profit is https://doi.org/10.3322%2Fcaac.20073 making per month?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%2C%202010&journal=Cancer%20J%20Clin&doi=10.3322%2Fcaac.20073&volume=60&pages=277-300&publication_year=2010&author=Jemal%2CA&author=Siegel%2CR&author=Xu%2CJ&author=Ward%2CE is on a monthly basis
• How much does https://doi.org/10.1016%2Fj.ejso.2008.03.015 net monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18502088 income
• How much income does http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20chemotherapy%20for%20locally%20advanced%20breast%20cancer%3A%20a%20review%20of%20the%20literature%20and%20future%20directions&journal=Eur%20J%20Surg%20Oncol&doi=10.1016%2Fj.ejso.2008.03.015&volume=35&pages=113-122&publication_year=2009&author=Mathew%2CJ&author=Asgeirsson%2CKS&author=Cheung%2CKL&author=Chan%2CS&author=Dahda%2CA&author=Robertson%2CJF have?
• https://doi.org/10.1002%2Fpath.889 income
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11568890?
• How much does http://scholar.google.com/scholar_lookup?&title=Towards%20a%20novel%20classification%20of%20human%20malignancies%20based%20on%20gene%20expression%20patterns&journal=J%20Pathol&doi=10.1002%2Fpath.889&volume=195&pages=41-52&publication_year=2001&author=Alizadeh%2CAA&author=Ross%2CDT&author=Perou%2CCM&author=Rjin%2CM bring in each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Clinical%20course%20of%20breast%20cancer%20patients%20with%20complete%20pathologic%20primary%20tumor%20an%20axillary%20lymph%20node%20response%20to%20doxorubicin-based%20neoadjuvant%20chemotherapy&journal=J%20Clin%20Oncol&volume=17&pages=460-469&publication_year=1999&author=Kuere%2CHM&author=Newman%2CLA&author=Smith%2CTL&author=Ames%2CFC&author=Hunt%2CKK&author=Dhingra%2CK&author=Theriault%2CRL&author=Singh%2CG&author=Binkley%2CSM&author=Sneige%2CN&author=Buchholz%2CTA&author=Ross%2CMI&author=McNeese%2CMD&author=Buzdar%2CAU&author=Hortobagyi%2CGN&author=Singletary%2CSE pull in monthly?
• https://doi.org/10.1016%2FS0960-9776%2811%2970312-5's revenue stream
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Lessons%20from%20the%20neoadjuvant%20setting%20on%20how%20best%20to%20choose%20adjuvant%20therapies&journal=Breast&doi=10.1016%2FS0960-9776%2811%2970312-5&volume=20&pages=S142-S145&publication_year=2011&author=Minckwitz%2CG&author=Loibl%2CS&author=Maisch%2CA&author=Untch%2CM?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18940745?
• http://scholar.google.com/scholar_lookup?&title=Tumor%20molecular%20subtyping%20according%20to%20hormone%20receptors%20and%20HER2%20status%20defines%20different%20pathological%20complete%20response%20to%20neoadjuvant%20chemotherapy%20in%20patients%20with%20locallyadvanced%20breast%20cancer&journal=Clin%20Transl%20Oncol&doi=10.1007%2Fs12094-008-0265-y&volume=10&publication_year=2008&author=Sanchez-Munoz%2CA&author=Garcia-Tapiador%2CAM&author=Martinez-Ortega%2CE&author=Due%C3%B1as-Garc%C3%ADa%2CR&author=Ja%C3%A9n-Morago%2CA&author=Ortega-Granados%2CAL&author=Fern%C3%A1ndez-Navarro%2CM&author=Torre-Cabrera%2CC&author=Due%C3%B1as%2CB&author=Rueda%2CAI&author=Morales%2CF&author=Ram%C3%ADrez-Torosa%2CC&author=Mart%C3%ADn-Salvago%2CMD&author=S%C3%A1nchez-Rovira%2CP income
• Revenue of https://doi.org/10.1200%2FJCO.2006.05.6861
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16896004 generate?
• Profit of http://scholar.google.com/scholar_lookup?&title=Pharmacogenomic%20predictor%20of%20sensitivity%20to%20preoperative%20chemotherapy%20with%20paclitaxel%20and%20fluorouracil%2C%20doxorubicin%2C%20and%20cyclophosphamide%20in%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.05.6861&volume=24&pages=4236-4244&publication_year=2006&author=Hess%2CKR&author=Anderson%2CK&author=Symmans%2CWF&author=Valero%2CV&author=Ibrahim%2CN&author=Mejia%2CJA&author=Booser%2CD&author=Theriault%2CRL&author=Buzdar%2CAU&author=Dempsey%2CPJ&author=Rouzier%2CR&author=Sneige%2CN&author=Ross%2CJS&author=Vidaurre%2CT&author=G%C3%B3mez%2CHL&author=Hortobagyi%2CGN&author=Pusztai%2CL
• What's the financial intake of https://doi.org/10.1158%2F1078-0432.CCR-05-0507?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16243804
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=p53%20Codon%2072%20polymorphism%20predicts%20the%20pathologic%20response%20to%20neoadjuvant%20chemotherapy%20in%20patients%20with%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-0507&volume=11&pages=7328-7333&publication_year=2005&author=Xu%2CY&author=Yao%2CL&author=Ouyang%2CT&author=Li%2CJ&author=Wang%2CT&author=Fan%2CZ&author=Lin%2CB&author=Lu%2CY&author=Xie%2CY each month?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17976237's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=Prognostic%20impact%20of%20clinicopathologic%20parameters%20in%20stage%20II%2FIII%20breast%20cancer%20treated%20with%20neoadjuvant%20docetaxel%20and%20doxorubicin%20chemotherapy%3A%20paradoxical%20features%20of%20the%20triple%20negative%20breast%20cancer&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-7-203&volume=7&publication_year=2007&author=Keam%2CB&author=Im%2CSA&author=Kim%2CHJ&author=Oh%2CDY&author=Kim%2CJH&author=Lee%2CSH&author=Chie%2CEK&author=Han%2CW&author=Kim%2CDW&author=Moon%2CWK&author=Kim%2CTY&author=Park%2CIA&author=Noh%2CDY&author=Heo%2CDS&author=Ha%2CSW&author=Bang%2CYJ rake in every month?
• How much revenue does https://doi.org/10.1038%2Fsj.bjc.6602419 generate?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15700032?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=The%20relationship%20between%20tumor%20T-lymphocyte%20infiltration%2C%20the%20systemic%20inflammatory%20response%20and%20survival%20in%20patients%20undergoing%20curative%20resection%20for%20colorectal%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6602419&volume=92&pages=651-654&publication_year=2005&author=Canna%2CK&author=McArdle%2CPA&author=McMillan%2CDC&author=McNicol%2CAM&author=Smith%2CGW&author=McKee%2CRF&author=McArdle%2CCS
• Learn about the earnings of https://doi.org/10.1002%2F1097-0142%2819890101%2963%3A1%3C102%3A%3AAID-CNCR2820630117%3E3.0.CO%3B2-T
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2642728
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Functional%20and%20phenotypic%20analysis%20of%20tumor-infiltrating%20lymphocytes%20isolated%20from%20human%20primary%20and%20metastatic%20liver%20tumors%20and%20cultured%20in%20recombinant%20interleukin-2&journal=Cancer&doi=10.1002%2F1097-0142%2819890101%2963%3A1%3C102%3A%3AAID-CNCR2820630117%3E3.0.CO%3B2-T&volume=63&pages=102-111&publication_year=1989&author=Takagi%2CS&author=Chen%2CK&author=Schwarz%2CR&author=Iwatsuki%2CS&author=Herberman%2CRB&author=Whiteside%2CTL generate?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19338264
• How much does http://scholar.google.com/scholar_lookup?&title=Focus%20on%20TILs%3A%20prognostic%20significance%20of%20tumor%20infiltrating%20lymphocytes%20in%20human%20melanoma&journal=Cancer%20Immun&volume=9&publication_year=2009&author=Oble%2CDA&author=Loewe%2CR&author=Yu%2CP&author=Mihm%2CMC make?
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17705880?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Inflammation%20and%20breast%20cancer%3A%20balancing%20immune%20response-crosstalk%20between%20adaptive%20and%20innate%20immune%20cells%20during%20breast%20cancer%20progression&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr1746&volume=9&publication_year=2007&author=DeNardo%2CDG&author=Coussens%2CLM making per month?
• Earnings of https://doi.org/10.1016%2Fj.ejca.2009.02.014
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19286369 bring in each month?
• Profit of http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20significance%20of%20inflammation%20and%20medullary%20histological%20type%20in%20invasive%20carcinoma%20of%20the%20breast&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2009.02.014&volume=45&pages=1780-1787&publication_year=2009&author=Rakha%2CEA&author=Aleskandarany%2CM&author=Sayed%2CME&author=Blamey%2CRW&author=Elston%2CCW&author=Ellis%2CIO&author=Lee%2CAH
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18294387's total income per month
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=FOXP3%2B%20Tregs%20and%20B7-H1%2B%2FPD-1%2B%20T%20lymphocytes%20co-infiltrate%20the%20tumor%20tissues%20of%20high-risk%20breast%20cancer%20patients%3A%20implication%20for%20immunotherapy&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-8-57&volume=8&publication_year=2008&author=Ghebeh%2CH&author=Barhoush%2CE&author=Tulbah%2CA&author=Elkum%2CN&author=Al-Tweigeri%2CT&author=Dermime%2CS?
• https://doi.org/10.1200%2FJCO.2010.30.5037's revenue stream
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21483002's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=Tumour-infiltrating%20CD8%2B%20lymphocytes%20predict%20clinical%20outcome%20in%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2010.30.5037&volume=29&pages=1949-1955&publication_year=2011&author=Mahmoud%2CSM&author=Paish%2CEC&author=Powe%2CDG&author=Macmillan%2CRD&author=Grainge%2CMJ&author=Lee%2CAH&author=Ellis%2CIO&author=Green%2CAR net monthly?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22420471?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=CD8%2B%20lymphocyte%20infiltration%20is%20an%20independent%20favourable%20prognostic%20indicator%20in%20basal-like%20breast%20cancer&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr3148&volume=14&publication_year=2012&author=Liu%2CS&author=Lachapelle%2CJ&author=Leung%2CS&author=Gao%2CD&author=Foulkes%2CWD&author=Nielsen%2CTO
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20092246 produce monthly?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Possible%20significance%20of%20differences%20in%20proportions%20of%20cytotoxic%20T%20cells%20and%20B-lineage%20cells%20in%20the%20tumour-infiltrating%20lymphocytes%20of%20typical%20and%20atypical%20medullary%20carcinomas%20of%20the%20breast&journal=Cancer%20Immun&volume=10&publication_year=2010&author=Lim%2CKH&author=Telisinghe%2CPU&author=Abdullah%2CMS&author=Ramasamy%2CR
• Learn how profitable https://doi.org/10.1126%2Fscience.1079490 is on a monthly basis
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12522256 pull in?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Control%20of%20regulatory%20T%20cell%20development%20by%20the%20transcription%20factor%20FoxP3&journal=Science&doi=10.1126%2Fscience.1079490&volume=299&pages=1057-1061&publication_year=2003&author=Hori%2CS&author=Monura%2CT&author=Sakaguchi%2CS?
• How much does https://doi.org/10.1038%2Fmodpathol.2008.160 pull in monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18820666's financial summary
• How much does http://scholar.google.com/scholar_lookup?&title=Immunosuppressive%20regulatory%20Tcells%20are%20associated%20with%20aggressive%20breast%20cancer%20phenotypes%3A%20a%20potential%20therapeutic%20target&journal=Mod%20Pathol&doi=10.1038%2Fmodpathol.2008.160&volume=21&pages=1527-1532&publication_year=2008&author=Bohling%2CSD&author=Allison%2CKH bring in each month?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21717105
• How much does http://scholar.google.com/scholar_lookup?&title=CD8%28%2B%29%20cytotoxic%20T%20cell%20and%20FOXP3%28%2B%29%20regulatory%20Tcell%20infiltration%20in%20relation%20to%20breast%20cancer%20survival%20and%20molecular%20subtypes&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-011-1647-3&volume=130&pages=645-655&publication_year=2011&author=Liu%2CF&author=Lang%2CR&author=Zhao%2CJ&author=Zhang%2CX&author=Pringle%2CGA&author=Fan%2CY&author=Yin%2CD&author=Gu%2CF&author=Yao%2CZ&author=Fu%2CL pull in monthly?
• What's the financial gain of https://doi.org/10.1200%2FJCO.2009.23.7370?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19917869's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20lymphocytes%20as%20an%20independent%20predictor%20of%20response%20to%20neoadjuvant%20chemotherapy%20in%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.23.7370&volume=28&pages=105-113&publication_year=2010&author=Denkert%2CC&author=Loibl%2CS&author=Noske%2CA&author=Roller%2CM&author=M%C3%BCller%2CBM&author=Komor%2CM&author=Budczies%2CJ&author=Darb-Esfahani%2CS&author=Kronenwett%2CR&author=Hanusch%2CC&author=T%C3%B6rne%2CC&author=Weichert%2CW&author=Engels%2CK&author=Solbach%2CC&author=Schrader%2CI&author=Dietel%2CM&author=Minckwitz%2CG generate monthly?
• What's the monthly income of https://doi.org/10.1158%2F1078-0432.CCR-07-4491?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18413832 bring in?
• How much does http://scholar.google.com/scholar_lookup?&title=Pathologic%20complete%20response%20to%20neoadjuvant%20chemotherapy%20of%20breast%20cancer%20is%20associated%20with%20the%20disappearence%20of%20tumor-infiltrating%20FOXP3%2B%20regulatory%20Tcells&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-4491&volume=14&pages=2413-2420&publication_year=2008&author=Ladoire%2CS&author=Arnould%2CL&author=Apetoh%2CL&author=Coudert%2CB&author=Martin%2CF&author=Chauffert%2CB&author=Fumoleau%2CP&author=Ghiringhelli%2CF bring in each month?
• What's the income generated by https://doi.org/10.1002%2Fpath.2866 each month?
• See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21437909 makes per month
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=In%20situ%20immune%20response%20after%20neoadjuvant%20chemotherapy%20for%20breast%20cancer%20predicts%20survival&journal=J%20Pathol&doi=10.1002%2Fpath.2866&volume=224&pages=389-400&publication_year=2011&author=Ladoire%2CS&author=Mignot%2CG&author=Dabakuyo%2CS&author=Arnould%2CL&author=Apetoh%2CL&author=R%C3%A9b%C3%A9%2CC&author=Coudert%2CB&author=Martin%2CF&author=Bizollon%2CMH&author=Vanoli%2CA&author=Coutant%2CC&author=Fumoleau%2CP&author=Bonnetain%2CF&author=Ghiringhelli%2CF?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22842982's gross income?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Peritumoral%20FOXP3%2B%20regulatory%20Tcell%20is%20sensitive%20to%20chemotherapy%20while%20intratumoral%20FOXP3%2B%20regulatory%20T%20cell%20is%20prognostic%20predictor%20of%20breast%20cancer%20patients&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-012-2132-3&volume=135&pages=459-467&publication_year=2012&author=Liu%2CF&author=Li%2CY&author=Ren%2CM&author=Zhang%2CX&author=Guo%2CX&author=Lang%2CR&author=Gu%2CF&author=Fu%2CL
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10888772 make?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Prognostic%20factors%20in%20breast%20cancer.%20College%20of%20American%20pathologists%20consensus%20statement%201999&journal=Arch%20Pathol%20Lab%20Med&volume=124&pages=966-978&publication_year=2000&author=Fitzgibbons%2CPL&author=Page%2CDL&author=Weaver%2CD&author=Thor%2CAD&author=Allred%2CDC&author=Clark%2CGM&author=Ruby%2CSG&author=O%E2%80%99Malley%2CF&author=Simpson%2CJF&author=Connolly%2CJL&author=Hayes%2CDF&author=Edge%2CSB&author=Lichter%2CA&author=Schnitt%2CSJ earns monthly
• How much revenue does https://doi.org/10.1016%2Fj.ejca.2008.10.026 produce monthly?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19097774?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=New%20response%20evaluation%20criteria%20in%20solid%20tumours%3A%20revised%20RECIST%20guideline%20%28version%201.1%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2008.10.026&volume=45&pages=228-247&publication_year=2009&author=Eisenhauer%2CEA&author=Therasse%2CP&author=Bogaerts%2CJ&author=Schwartz%2CLH&author=Sargent%2CD&author=Ford%2CR&author=Dancey%2CJ&author=Arbuck%2CS&author=Gwyther%2CS&author=Mooney%2CM&author=Rubinstein%2CL&author=Shankar%2CL&author=Dodd%2CL&author=Kaplan%2CR&author=Lacombe%2CD&author=Verweij%2CJ
• Get to know what's the income of https://doi.org/10.3109%2F0284186X.2012.731520
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23075422 generate?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Prognostic%20impact%20of%20FOXP3%20expression%20in%20triple-negative%20breast%20cancer&journal=Acta%20Oncol&doi=10.3109%2F0284186X.2012.731520&volume=52&pages=73-81&publication_year=2013&author=Lee%2CS&author=Cho%2CEY&author=Park%2CYH&author=Ahn%2CJS&author=Im%2CYH produce monthly?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17629742
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Prognostic%20factors%20affecting%20locoregional%20recurrence%20in%20patients%20with%20stage%20IIIB%20noninflammatory%20breast%20cancer&journal=World%20J%20Surg&doi=10.1007%2Fs00268-007-9139-7&volume=31&pages=1724-1730&publication_year=2007&author=G%C3%BClben%2CK&author=Berbero%C4%9Flu%2CU&author=Cengiz%2CA&author=Altinyollar%2CH?
• How much does https://doi.org/10.1001%2Farchsurg.141.6.567 rake in every month?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16785357
• How much profit does http://scholar.google.com/scholar_lookup?&title=A%20single-center%20experience%20with%20inflammatory%20breast%20cancer%2C%201985%E2%80%932003&journal=Arch%20Surg&doi=10.1001%2Farchsurg.141.6.567&volume=141&pages=567-573&publication_year=2006&author=Smoot%2CRL&author=Koch%2CCA&author=Degnim%2CAC&author=Sterioff%2CS&author=Donohue%2CJH&author=Grant%2CCS&author=Barnes%2CSA&author=Gullerud%2CRE&author=Hobday%2CTJ&author=Farley%2CDR generate?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20443786 earns monthly
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20chemotherapy%20of%20breast%20cancer%3A%20tumor%20markers%20as%20predictors%20of%20pathologic%20response%2C%20recurrence%2C%20and%20survival&journal=Breast%20J&volume=16&pages=362-368&publication_year=2010&author=Precht%2CLM&author=Lowe%2CKA&author=Atwood%2CM&author=Beatty%2CJD have monthly?
• https://doi.org/10.1245%2Fs10434-010-1008-1's financial summary
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20373039
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=The%20relevance%20of%20breast%20cancer%20subtypes%20in%20the%20outcome%20of%20neoadjuvant%20chemotherapy&journal=Ann%20Surg%20Oncol&doi=10.1245%2Fs10434-010-1008-1&volume=17&pages=2411-2418&publication_year=2010&author=Straver%2CME&author=Rutgers%2CEJ&author=Rodenhuis%2CS&author=Linn%2CSC&author=Loo%2CCE&author=Wesseling%2CJ&author=Russell%2CNS&author=Oldenburg%2CHS&author=Antonini%2CN&author=Vrancken%20Peeters%2CMT have monthly?
• What is the monthly revenue of https://doi.org/10.1093%2Fannonc%2Fmdm509?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17986623
• How much does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20ER%2C%20PgR%2C%20HER1%2C%20HER2%2C%20and%20response%3A%20a%20study%20of%20preoperative%20chemotherapy&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdm509&volume=19&pages=465-472&publication_year=2008&author=Colleoni%2CM&author=Viale%2CG&author=Zahrieh%2CD&author=Bottiglieri%2CL&author=Gelber%2CRD&author=Veronesi%2CP&author=Balduzzi%2CA&author=Torrisi%2CR&author=Luini%2CA&author=Intra%2CM&author=Dellapasqua%2CS&author=Cardillo%2CA&author=Ghisini%2CR&author=Peruzzotti%2CG&author=Goldhirsch%2CA generate monthly?
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19758440?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Identification%20of%20biology-based%20breast%20cancer%20types%20with%20distinct%20predicitive%20and%20prognostic%20features%3A%20role%20of%20steroid%20hormone%20and%20HER2%20receptor%20expression%20in%20patients%20treated%20with%20neoadjuvant%20anthracycline%2Ftaxane-based%20chemotherapy&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr2363&volume=11&publication_year=2009&author=Darb-Esfahani%2CS&author=Loibl%2CS&author=Muller%2CBM&author=Roller%2CM&author=Denkert%2CC&author=Komor%2CM&author=Schl%C3%BCns%2CK&author=Blohmer%2CJU&author=Budczies%2CJ&author=Gerber%2CB&author=Noske%2CA&author=Bois%2CA&author=Weichert%2CW&author=Jackisch%2CC&author=Dietel%2CM&author=Richter%2CK&author=Kaufmann%2CM&author=Minckwitz%2CG?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22198468?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Chemotherapy%20response%20and%20recurrence-free%20survival%20in%20neoadjuvant%20breast%20cancer%20depends%20on%20biomarker%20profiles%3A%20results%20from%20the%20I-SPY%201%20TRIAL%20%28CALBG%20150007%2F150012%3BACRIN%206657%29&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-011-1895-2&volume=132&pages=1049-1062&publication_year=2012&author=Esserman%2CLJ&author=Berry%2CDA&author=Cheang%2CMCU
• What's the financial intake of https://doi.org/10.1016%2Fj.ejca.2012.05.023?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22766518's total income per month
• How much money does http://scholar.google.com/scholar_lookup?&title=Meta-analysis%20of%20the%20association%20of%20breast%20cancer%20subtype%20and%20pathologic%20complete%20response%20to%20neoadjuvant%20chemotherapy&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2012.05.023&volume=48&pages=3342-3354&publication_year=2012&author=Houssami%2CN&author=Macaskill%2CP&author=Minckwitz%2CG&author=Marinovich%2CML&author=Mamounas%2CE generate?
• What's the monthly money flow for https://doi.org/10.1038%2Fbjc.2012.524?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23169287
• http://scholar.google.com/scholar_lookup?&title=Tumour-infiltrating%20FOXP3%2B%20lymphocytes%20are%20asociated%20with%20cytotoxic%20immune%20responses%20and%20good%20clinical%20outcome%20in%20oestrogen%20receptor-negative%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.2012.524&volume=108&pages=155-162&publication_year=2013&author=West%2CNR&author=Kost%2CSE&author=Martin%2CSD&author=Milne%2CK&author=deLeeuw%2CRJ&author=Nelson%2CBH&author=Watson%2CPH's revenue stream
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18802696?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Paclitaxel%20reduces%20regulatory%20Tcell%20numbers%20and%20inhibitory%20function%20and%20enhances%20the%20anti-tumor%20effects%20of%20the%20TLR9%20agonist%20PF-3512676%20in%20the%20mouse&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-008-0586-2&volume=58&pages=615-628&publication_year=2009&author=Vicari%2CAP&author=Luu%2CR&author=Zhang%2CN&author=Patel%2CS&author=Makinen%2CSR&author=Hanson%2CDC&author=Weeratna%2CRD&author=Krieg%2CAM?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22986814
• What's the income of http://scholar.google.com/scholar_lookup?&title=Intratumoral%20regulatory%20T%20cells%20as%20an%20independent%20predictive%20factor%20for%20pathological%20complete%20response%20to%20neoadjuvant%20paclitaxel%20followed%20by%205-FU%2Fepirubicin%2Fcyclophosphamide%20in%20breast%20cancer%20patients&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-012-2245-8&volume=136&pages=107-116&publication_year=2012&author=Oda%2CN&author=Shimazu%2CK&author=Naoi%2CY&author=Morimoto%2CK&author=Shimomura%2CA&author=Shimoda%2CM&author=Kagara%2CN&author=Maruyama%2CN&author=Kim%2CSJ&author=Noguchi%2CS?
• Revenue of https://doi.org/10.1158%2F1078-0432.CCR-09-1844
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20145162
• How much does http://scholar.google.com/scholar_lookup?&title=The%20predictive%20value%20of%20HLA%20class%20I%20tumor%20cell%20expression%20and%20presence%20of%20intratumoral%20Tregs%20for%20chemotherapy%20in%20patients%20with%20early%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-1844&volume=16&pages=1272-1280&publication_year=2010&author=Kruijf%2CEM&author=Nes%2CJG&author=Sajet%2CA&author=Tummers%2CQR&author=Putter%2CH&author=Osanto%2CS&author=Speetjens%2CFM&author=Smit%2CVT&author=Liefers%2CGJ&author=Velde%2CCJ&author=Kuppen%2CPJ pull in?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16960692?
• How much money does http://scholar.google.com/scholar_lookup?&title=Metronomic%20cyclophoshamide%20regimen%20selectively%20depletes%20CD4%C2%A0%2B%C2%A0CD25%2B%20regulatory%20T%20cells%20and%20restores%20T%20and%20NK%20effector%20functions%20in%20end%20stage%20cancer%20patients&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-006-0225-8&volume=56&pages=641-648&publication_year=2007&author=Ghiringhelli%2CF&author=Menard%2CC&author=Puig%2CPE&author=Ladoire%2CS&author=Roux%2CS&author=Martin%2CF&author=Solary%2CE&author=Cesne%2CA&author=Zitvogel%2CL&author=Chauffert%2CB generate?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11325840's total income per month
• How much income is http://scholar.google.com/scholar_lookup?&title=Cyclophosphamide%2C%20doxorubicin%2C%20and%20paclitaxel%20enhance%20the%20antitumor%20immune%20response%20of%20granulocyte%2Fmacrophage-colony%20stimulating%20factor-secreting%20whole-cell%20vaccines%20in%20HER-2%2Fneu%20tolerized%20mice&journal=Cancer%20Res&volume=61&pages=3689-3697&publication_year=2001&author=Machiels%2CJP&author=Reilly%2CRT&author=Emens%2CLA&author=Ercolini%2CAM&author=Lei%2CRY&author=Weintraub%2CD&author=Okoye%2CFI&author=Jaffee%2CEM earning monthly?
• Find out how much https://doi.org/10.1002%2Fijc.23392 earns monthly
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18224687 earn?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=CCL17%20and%20CCL22%20chemokines%20within%20tumor%20microenvironment%20are%20related%20to%20accumulation%20of%20Foxp3%2B%20regulatory%20T%20cells%20in%20gastric%20cancer&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.23392&volume=122&pages=2286-2293&publication_year=2008&author=Mizukami%2CY&author=Kono%2CK&author=Kawaguchi%2CY&author=Akaike%2CH&author=Kamimura%2CK&author=Sugai%2CH&author=Fujii%2CH
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22621334
• What's http://scholar.google.com/scholar_lookup?&title=Local%E2%80%93regional%20control%20according%20to%20surrogate%20markers%20of%20breast%20cancer%20subtypes%20and%20response%20to%20neoadjuvant%20chemotherapy%20in%20breast%20cancer%20patients%20undergoing%20breast%20conserving%20therapy&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr3198&volume=14&publication_year=2012&author=Caudle%2CAS&author=Yu%2CT&author=Tucker%2CSL&author=Bedrosian%2CI&author=Litton%2CJK&author=Gonzalez-Angulo%2CAM&author=Hoffman%2CK&author=Meric-Bernstam%2CF&author=Hunt%2CKK&author=Buchholz%2CTA&author=Mittendorf%2CEA's gross income?
• What's the monthly income of https://doi.org/10.1634%2Ftheoncologist.2007-0107?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18245008 bring in?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20initial%20clinical%20disease%20stage%20after%20achieving%20pathological%20complete%20response&journal=Oncologist&doi=10.1634%2Ftheoncologist.2007-0107&volume=13&pages=6-15&publication_year=2008&author=Dawood%2CS&author=Broglio%2CK&author=Kau%2CSW&author=Islam%2CR&author=Symmans%2CWF&author=Buchholz%2CTA&author=McGuire%2CSE&author=Meric-Bernstam%2CF&author=Cristofanilli%2CM&author=Hortob%C3%A1gyi%2CGN&author=Gonzalez-Angulo%2CAM?
• What is the earnings of https://doi.org/10.1200%2FJCO.2005.04.1665?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16606972 gross monthly?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Sequential%20preoperative%20or%20postoperative%20docetaxel%20added%20to%20preoperative%20doxorubicin%20plus%20cyclophosphamide%20for%20operable%20breast%20cancer%3A%20National%20Surgical%20Adjuvant%20Breast%20and%20Bowel%20Project%20Protocol%20B-27&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.04.1665&volume=24&pages=2019-2027&publication_year=2006&author=Bear%2CHD&author=Anderson%2CS&author=Smith%2CRE&author=Geyer%2CCE&author=Mamounas%2CEP&author=Fisher%2CB&author=Brown%2CAM&author=Robidoux%2CA&author=Margolese%2CR&author=Kahlenberg%2CMS&author=Paik%2CS&author=Soran%2CA&author=Wickerham%2CDL&author=Wolmark%2CN
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8874335?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Annual%20hazard%20rates%20of%20recurrence%20for%20breast%20cancer%20after%20primary%20therapy&journal=J%20Clin%20Oncol&volume=14&pages=2738-2746&publication_year=1996&author=Saphner%2CT&author=Tormey%2CDC&author=Gray%2CR have monthly?
• How much money does https://citation-needed.springer.com/v2/references/10.1007/s10585-013-9602-9?format=refman&flavour=references make?
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lutfiye%20Demir?
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lutfiye%20Demir%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Seyran%20Yigit income
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Seyran%20Yigit%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hulya%20Ellidokuz?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hulya%20Ellidokuz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cigdem%20Erten bring in?
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cigdem%20Erten%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Isil%20Somali
• What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Isil%20Somali%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuksel%20Kucukzeybek rake in every month?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuksel%20Kucukzeybek%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ahmet%20Alacacioglu's gross income?
• See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ahmet%20Alacacioglu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Suna%20Cokmert produce monthly?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Suna%20Cokmert%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alper%20Can
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alper%20Can%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Murat%20Akyol?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Murat%20Akyol%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ahmet%20Dirican generate?
• What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ahmet%20Dirican%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vedat%20Bayoglu?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vedat%20Bayoglu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aysegul%20Akder%20Sari
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aysegul%20Akder%20Sari%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mustafa%20Oktay%20Tarhan
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mustafa%20Oktay%20Tarhan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://s100.copyright.com/AppDispatchServlet?title=Predictive%20and%20prognostic%20factors%20in%20locally%20advanced%20breast%20cancer%3A%20effect%20of%20intratumoral%20FOXP3%2B%20Tregs&author=Lutfiye%20Demir%20et%20al&contentID=10.1007%2Fs10585-013-9602-9©right=Springer%20Science%2BBusiness%20Media%20Dordrecht&publication=0262-0898&publicationDate=2013-07-09&publisherName=SpringerNature&orderBeanReset=true generate monthly?
• How much does https://citation-needed.springer.com/v2/references/10.1007/s10585-013-9602-9?format=refman&flavour=citation make?
• Check the income stats for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• How much profit does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research make?
• What are the total earnings of https://www.springernature.com/gp/products?
• Income figures for https://www.springernature.com/gp/librarians
• Earnings of https://www.springernature.com/gp/societies
• How much does https://www.springernature.com/gp/partners bring in each month?
• How much does https://www.springer.com/ net monthly?
• Profit of https://www.nature.com/
• How much revenue does https://www.biomedcentral.com/ bring in?
• Financial intake of https://www.palgrave.com/
• What's the monthly money flow for https://www.apress.com/?
• How much does https://www.springernature.com/gp/legal/ccpa net monthly?
• How much does https://www.springernature.com/gp/info/accessibility earn?
• What are the earnings of https://support.springernature.com/en/support/home?
• Earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
• How much does https://www.springernature.com/ earn?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js